The Recall Desk
ModerateFDA (Drugs)·D-0492-2020·Announced 2019-11-27

Washington Homeopathic Products Recalls Calcarea Phosphorica 6X Tablets

Washington Homeopathic Products, Inc. is recalling 681 bottles of Calcarea Phosphorica 6X tablets because they were not manufactured under current good manufacturing practices.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations, and the hazard is a manufacturing deviation rather than a specific contamination or defect causing harm.

Plain-English summary

Washington Homeopathic Products, Inc. is recalling 681 bottles of Calcarea Phosphorica 6X Tablets, 300-count bottle, 30g. The product was manufactured in India exclusively for Washington Homeopathic Products, Inc. The affected lot numbers are BR18C282 and BR18K166.

The recall was initiated because the products were not manufactured under current good manufacturing practices (CGMP). The FDA has classified this recall as Class II.

The product was distributed nationwide throughout the United States, Canada, and Saudi Arabia. Consumers should stop using the product and contact Washington Homeopathic Products, Inc. for further instructions.

The recalled product

Product
Calcarea Phosphorica 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64189 7.
Affected units
681

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot #: BR18C282 and BR18K166

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 16 recalled by Washington Homeopathic Products, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 16 products in this recall →